Related references
Note: Only part of the references are listed.Ligand-Installed Nanocarriers toward Precision Therapy
Peng Mi et al.
ADVANCED MATERIALS (2020)
Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications
Shoaib Iqbal et al.
BIOMACROMOLECULES (2020)
Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo
Yaohua Wei et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Cell-Type-Specific CRISPR/Cas9 Delivery by Biomimetic Metal Organic Frameworks
Mram Z. Alyami et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
Sejin Son et al.
NANO LETTERS (2020)
Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations
Hyunbo Shim
BIOMOLECULES (2020)
CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice
Yinan Zhong et al.
JOURNAL OF CONTROLLED RELEASE (2020)
CRISPR/Cas9 for cancer research and therapy
Tianzuo Zhan et al.
SEMINARS IN CANCER BIOLOGY (2019)
mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells
Bo Lou et al.
BIOCONJUGATE CHEMISTRY (2019)
Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells
Yu Yi et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Antibody-Drug Conjugate-Based Therapeutics: State of the Science
Michael J. Birrer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy
Xinlong Zang et al.
MOLECULAR PHARMACEUTICS (2019)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Development of CLAN Nanomedicine for Nucleic Acid Therapeutics
Cong-Fei Xu et al.
SMALL (2019)
Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo
Yaohua Wei et al.
ACTA BIOMATERIALIA (2019)
Antibody-Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index
Steven Coats et al.
CLINICAL CANCER RESEARCH (2019)
Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness
Angela Molina-Crespo et al.
CLINICAL CANCER RESEARCH (2019)
Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo
Jing Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133
Hongran Yin et al.
MOLECULAR THERAPY (2019)
Near-Infrared Photoimmunotherapy of Cancer
Hisataka Kobayashi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Small, Traceable, Endosome-Disrupting, and Bioresponsive Click Nanogels Fabricated via Microfluidics for CD44-Targeted Cytoplasmic Delivery of Therapeutic Proteins
Ke Huang et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination
Dunwan Zhu et al.
BIOMATERIALS (2019)
Antibody-drug conjugates- stability and formulation
Corinna Duerr et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2019)
Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Oncoprotein Inhibitor Rigosertib Loaded in ApoE-Targeted Smart Polymersomes Reveals High Safety and Potency against Human Glioblastoma in Mice
Huazhen Qin et al.
MOLECULAR PHARMACEUTICS (2019)
Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors
Min Qiu et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures
Hongliang He et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
CD44-Specific A6 Short Peptide Boosts Targetability and Anticancer Efficacy of Polymersomal Epirubicin to Orthotopic Human Multiple Myeloma
Wenxing Gu et al.
ADVANCED MATERIALS (2019)
HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor
Lin Ding et al.
BIOMACROMOLECULES (2019)
Antibody-drug conjugates for cancer
Cindy H. Chau et al.
LANCET (2019)
Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping
Zhen Zheng et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Lucia Salvioni et al.
CANCERS (2019)
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies
Jinbing Xie et al.
BIOMATERIALS (2019)
Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA
Satoshi Uchida et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2019)
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
Steven Horwitz et al.
LANCET (2019)
Active Targeting of Cancer Cells by Nanobody Decorated Polypeptide Micelle with Bio-orthogonally Conjugated Drug
Simone A. Costa et al.
NANO LETTERS (2019)
Polymer-drug conjugate therapeutics: advances, insights and prospects
Iriny Ekladious et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akin Akinc et al.
NATURE NANOTECHNOLOGY (2019)
Efficient Intracellular Delivery of RNase A Using DNA Origami Carriers
Shuai Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Antibody-drug conjugates: recent advances in conjugation and linker chemistries
Kyoji Tsuchikama et al.
PROTEIN & CELL (2018)
Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression
Fengmei Pi et al.
NATURE NANOTECHNOLOGY (2018)
Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo
Weijing Yang et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
Ying-Li Luo et al.
ACS NANO (2018)
Customizing poly(lactic-co-glycolic acid) particles for biomedical applications
Edyta Swider et al.
ACTA BIOMATERIALIA (2018)
Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo
Weijing Yang et al.
ACTA BIOMATERIALIA (2018)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Tumor-Specific Self-Degradable Nanogels as Potential Carriers for Systemic Delivery of Anticancer Proteins
Qiuwen Zhu et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Polymer Vesicles: Modular Platforms for Cancer Theranostics
Fangyingkai Wang et al.
ADVANCED MATERIALS (2018)
Protein Toxin Chaperoned by LRP-1-Targeted Virus-Mimicking Vesicles Induces High-Efficiency Glioblastoma Therapy In Vivo
Yu Jiang et al.
ADVANCED MATERIALS (2018)
pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells
Lingling Ding et al.
BIOMACROMOLECULES (2018)
Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo
Philipp Michael Klein et al.
BIOMATERIALS (2018)
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia
Emily Y. Jen et al.
CLINICAL CANCER RESEARCH (2018)
Bioresponsive functional nanogels as an emerging platform for cancer therapy
Dechun Huang et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides
Yaqin Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells
A. Le Moignic et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo
Min Qiu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting
Lucia Martinez-Jothar et al.
JOURNAL OF CONTROLLED RELEASE (2018)
CD44 targeting biocompatible and biodegradable hyaluronic acid cross-linked zein nanogels for curcumin delivery to cancer cells: In vitro and in vivo evaluation
Hae-Yong Seok et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy
Changmai Chen et al.
MEDICINAL RESEARCH REVIEWS (2018)
GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment
Yan Zou et al.
MOLECULAR PHARMACEUTICS (2018)
Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer
Maryna Perepelyuk et al.
MOLECULAR PHARMACEUTICS (2018)
mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
Yuhua Wang et al.
MOLECULAR THERAPY (2018)
Dual-targeted nanomedicines for enhanced tumor treatment
Yaqin Zhu et al.
NANO TODAY (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma
J. M. Connors et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
Hong-Xia Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer A Phase 2 Clinical Trial
Karen A. Autio et al.
JAMA ONCOLOGY (2018)
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Denzil Furtado et al.
ADVANCED MATERIALS (2018)
Small-Sized and Robust Chimaeric Lipopepsomes: A Simple and Functional Platform with High Protein Loading for Targeted Intracellular Delivery of Protein Toxin in Vivo
Min Qiu et al.
CHEMISTRY OF MATERIALS (2018)
Dually Gated Polymersomes for Gene Delivery
Fangyingkai Wang et al.
NANO LETTERS (2018)
Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy
Liang Cheng et al.
ADVANCED HEALTHCARE MATERIALS (2018)
Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma
Yu Jiang et al.
ACS NANO (2018)
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster et al.
BRITISH JOURNAL OF CANCER (2018)
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
Hamideh Parhiz et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors
Bo-Ya Liu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Granzyme B-loaded, cell-selective penetrating and reduction-responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo
Weijing Yang et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Boosting RNAi therapy for orthotopic glioblastoma with nontoxic brain-targeting chimaeric polymersomes
Yanan Shi et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Peptide-decorated polymeric nanomedicines for precision cancer therapy
Huanli Sun et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy
Kazuhide Sato et al.
ACS CENTRAL SCIENCE (2018)
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
John P. A. Ioannidis et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies
Imke A. B. Pijpers et al.
ADVANCED THERAPEUTICS (2018)
Targeted chemotherapy for subcutaneous and orthotopic non-small cell lung tumors with cyclic RGD-functionalized and disulfide-crosslinked polymersomal doxorubicin
Yan Zou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
Aditya Bardia et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan
Rebecca Suk Heist et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery
Guojun Chen et al.
JOURNAL OF CONTROLLED RELEASE (2017)
αvβ3 Integrin-targeted reduction-sensitive micellarmertansine prodrug: Superb drug loading, enhanced stability, and effective inhibition of melanoma growth in vivo
Ping Zhong et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Nanogels for intracellular delivery of biotherapeutics
Dandan Li et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
Arman Jahangiri et al.
JOURNAL OF NEUROSURGERY (2017)
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 study
Peter C. Thuss-Patience et al.
LANCET ONCOLOGY (2017)
ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice
Ning Zhang et al.
MOLECULAR PHARMACEUTICS (2017)
A Targeted and Stable Polymeric Nanoformulation Enhances Systemic Delivery of mRNA to Tumors
Qixian Chen et al.
MOLECULAR THERAPY (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
FolamiRs: Ligand-targeted, vehicle-free delivery of microRNAs for the treatment of cancer
Esteban A. Orellana et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Advances in the delivery of RNA therapeutics: from concept to clinical reality
James C. Kaczmarek et al.
GENOME MEDICINE (2017)
Tools for translation: non-viral materials for therapeutic mRNA delivery
Khalid A. Hajj et al.
NATURE REVIEWS MATERIALS (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma
Chao Liang et al.
BIOMATERIALS (2017)
EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo
Yuan Fang et al.
ACTA BIOMATERIALIA (2017)
Virus-Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo
Yan Zou et al.
ADVANCED MATERIALS (2017)
Recent applications of PLGA based nanostructures in drug delivery
Maria Mir et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
Lingmin Zhang et al.
NPG ASIA MATERIALS (2017)
Bioresponsive Chimaeric Nanopolymersomes Enable Targeted and Efficacious Protein Therapy for Human Lung Cancers in Vivo
Weijing Yang et al.
CHEMISTRY OF MATERIALS (2017)
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-SN-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics
Allyson J. Ocean et al.
CANCER (2017)
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee et al.
CLINICAL CANCER RESEARCH (2017)
EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo
Jing Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Tumor associated macrophage-targeted microRNA delivery with dual-responsive polypeptide nanovectors for anti-cancer therapy
Lanlan Liu et al.
BIOMATERIALS (2017)
Phase 2 study of sacituzumab govitecan (IMMU-132), an anti-Trop-2/SN-38 antibody-drug conjugate (ADC), in patients with pretreated metastatic small-cell lung cancer (mSCLC)
Jhanelle E. Gray et al.
CANCER RESEARCH (2017)
Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs
Wei Huang et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization
Qihang Sun et al.
ADVANCED MATERIALS (2017)
Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB
Cuitian Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
miRNA nanotherapeutics for cancer
Aditya Ganju et al.
DRUG DISCOVERY TODAY (2017)
Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
Jennifer I. Hare et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels
Kun Liang et al.
ACTA BIOMATERIALIA (2016)
Recent progress in development of siRNA delivery vehicles for cancer therapy
Hyun Jin Kim et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Nanomedicine-mediated cancer stem cell therapy
Song Shen et al.
BIOMATERIALS (2016)
Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo
Yinan Zhong et al.
BIOMATERIALS (2016)
HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naive, HER2-positive, locally advanced/metastatic breast cancer
Kathy Miller et al.
BMC CANCER (2016)
Dual HER2 Targeting with Trastuzumab and Liposomal-Encapsulated Doxorubicin (MM-302) Demonstrates Synergistic Antitumor Activity in Breast and Gastric Cancer
Christopher W. Espelin et al.
CANCER RESEARCH (2016)
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Pedro Barata et al.
CANCER TREATMENT REVIEWS (2016)
Multifunctional Click Hyaluronic Acid Nanogels for Targeted Protein Delivery and Effective Cancer Treatment in Vivo
Jing Chen et al.
CHEMISTRY OF MATERIALS (2016)
Phase I Study of PSMA-Targeted Docetaxel-Containing Nanoparticle BIND-014 in Patients with Advanced Solid Tumors
Daniel D. Von Hoff et al.
CLINICAL CANCER RESEARCH (2016)
Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles
Yu Yi et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
Yan Zou et al.
JOURNAL OF CONTROLLED RELEASE (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery
Yanhua Liu et al.
MOLECULAR PHARMACEUTICS (2016)
A Phase I Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers
Arlene Siefker-Radtke et al.
MOLECULAR THERAPY (2016)
Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study
Kathleen F. Pirollo et al.
MOLECULAR THERAPY (2016)
Bankruptcy of nanomedicine firm worries drug developers
Heidi Ledford
NATURE (2016)
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
Hagop M. Kantarjian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
PolyMetformin combines carrier and anticancer activities for in vivo siRNA delivery
Yi Zhao et al.
NATURE COMMUNICATIONS (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
Thomas M. Cardillo et al.
BIOCONJUGATE CHEMISTRY (2015)
Anisamide-Decorated pH-Sensitive Degradable Chimaeric Polymersomes Mediate Potent and Targeted Protein Delivery to Lung Cancer Cells
Ling Lu et al.
BIOMACROMOLECULES (2015)
Clinical Translation of Nanomedicine
Yuanzeng Min et al.
CHEMICAL REVIEWS (2015)
Nucleic Acid Therapeutics Using Polyplexes: A Journey of 50 Years (and Beyond)
Ulrich Laechelt et al.
CHEMICAL REVIEWS (2015)
First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors
Alexander N. Starodub et al.
CLINICAL CANCER RESEARCH (2015)
Enhanced Delivery of SN-38 to Human Tumor Xenografts with an Anti-Trop-2-SN-38 Antibody Conjugate (Sacituzumab Govitecan)
Robert M. Sharkey et al.
CLINICAL CANCER RESEARCH (2015)
Efficacious delivery of protein drugs to prostate cancer cells by PSMA-targeted pH-responsive chimaeric polymersomes
Xiang Li et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+human breast tumor xenografts
Yinan Zhong et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Liposome-based glioma targeted drug delivery enabled by stable peptide ligands
Xiaoli Wei et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Trop-2 is a novel target for solid cancer therapy with sacituzumab govitecan (IMMU-132), an antibody-drug conjugate (ADC)
David M. Goldenberg et al.
ONCOTARGET (2015)
A Nanoparticle Carrying the p53 Gene Targets Tumors Including Cancer Stem Cells, Sensitizes Glioblastoma to Chemotherapy and Improves Survival
Sang-Soo Kim et al.
ACS NANO (2014)
Precise Engineering of siRNA Delivery Vehicles to Tumors Using Polyion Complexes and Gold Nanoparticles
Hyun Jin Kim et al.
ACS NANO (2014)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Promises and Pitfalls of Intracellular Delivery of Proteins
Ailing Fu et al.
BIOCONJUGATE CHEMISTRY (2014)
Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors
Yusuke Oe et al.
BIOMATERIALS (2014)
Trastuzumab emtansine: mechanisms of action and drug resistance
Mark Barok et al.
BREAST CANCER RESEARCH (2014)
Phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma
Pieter J. Gaillard et al.
CANCER RESEARCH (2014)
PEG-PLGA copolymers: Their structure and structure-influenced drug delivery applications
Keru Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®A Cerebral Open Flow Microperfusion Pilot Study
Thomas Birngruber et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Nanodelivery Systems for Nucleic Acid Therapeutics in Drug Resistant Tumors
Arun K. Iyer et al.
MOLECULAR PHARMACEUTICS (2014)
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Carla L. Esposito et al.
MOLECULAR THERAPY (2014)
Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies
Samir Mitragotri et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA
Jonathan E. Zuckerman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Ligand-targeted liposome design: challenges and fundamental considerations
Gavin T. Noble et al.
TRENDS IN BIOTECHNOLOGY (2014)
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Janet L. Markman et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Non-Viral Gene Delivery via Membrane-Penetrating, Mannose-Targeting Supramolecular Self-Assembled Nanocomplexes
Lichen Yin et al.
ADVANCED MATERIALS (2013)
Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy
Marina Talelli et al.
BIOMATERIALS (2013)
Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
Darren Lars Stirland et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors
Neil Senzer et al.
MOLECULAR THERAPY (2013)
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Tracy R. Daniels et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Regulation of iron transport and the role of transferrin
Konstantinos Gkouvatsos et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
U.S. Food and Drug Administration Approval Summary: Brentuximab Vedotin for the Treatment of Relapsed Hodgkin Lymphoma or Relapsed Systemic Anaplastic Large-Cell Lymphoma
R. Angelo de Claro et al.
CLINICAL CANCER RESEARCH (2012)
On the cellular processing of non-viral nanomedicines for nucleic acid delivery: Mechanisms and methods
Dries Vercauteren et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cells
Christoph Mamot et al.
JOURNAL OF DRUG TARGETING (2012)
Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
Christoph Mamot et al.
LANCET ONCOLOGY (2012)
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
Hagop Kantarjian et al.
LANCET ONCOLOGY (2012)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery
Hyukjin Lee et al.
NATURE NANOTECHNOLOGY (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Joseph G. Reynolds et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Pegylated Liposomal Doxorubicin A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma
Sean T. Duggan et al.
DRUGS (2011)
Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity
Jerzy Gubernator
EXPERT OPINION ON DRUG DELIVERY (2011)
Hyaluronan-CD44 interactions as potential targets for cancer therapy
Suniti Misra et al.
FEBS JOURNAL (2011)
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery
Ru Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes
Federico Perche et al.
JOURNAL OF DRUG TARGETING (2011)
Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
Federico Perche et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
The highly efficient delivery of exogenous proteins into cells mediated by biodegradable chimaeric polymersomes
Guijing Liu et al.
BIOMATERIALS (2010)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
Anjali Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Study of Trastuzumab-DM1, an HER2 Antibody-Drug Conjugate, Given Every 3 Weeks to Patients With HER2-Positive Metastatic Breast Cancer
Ian E. Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polymer therapeutics: Clinical applications and challenges for development Preface
Maria J. Vicent et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Polymersome delivery of siRNA and antisense oligonucleotides
Younghoon Kim et al.
JOURNAL OF CONTROLLED RELEASE (2009)
The First Targeted Delivery of siRNA in Humans via a Self-Assembling, Cyclodextrin Polymer-Based Nanoparticle: From Concept to Clinic
Mark E. Davis
MOLECULAR PHARMACEUTICS (2009)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome
Ryo Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Impact of single-chain fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells
Yu Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation in vitro and in vivo
Jeremy D. Heidel et al.
CLINICAL CANCER RESEARCH (2007)
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles
Derek W. Bartlett et al.
BIOCONJUGATE CHEMISTRY (2007)
Polymer therapeutics: Concepts and applications
R Haag et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo
C Mamot et al.
CANCER RESEARCH (2005)
Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer
Y Matsumura et al.
ANNALS OF ONCOLOGY (2004)
Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner
S Hosokawa et al.
BRITISH JOURNAL OF CANCER (2003)
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
M Weaver et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
The dawning era of polymer therapeutics
R Duncan
NATURE REVIEWS DRUG DISCOVERY (2003)
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia
PR Hamann et al.
BIOCONJUGATE CHEMISTRY (2002)
Mylotarg: antibody-targeted chemotherapy comes of age
EL Sievers et al.
CURRENT OPINION IN ONCOLOGY (2001)
Preclinical evaluation of the cardiotoxicity of PK2: A novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent
JW Hopewell et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2001)
Share Paper
